N
0.650
-0.01 (-1.75%)
| 前收盘价格 | 0.662 |
| 收盘价格 | 0.670 |
| 成交量 | 32,205 |
| 平均成交量 (3个月) | 98,004 |
| 市值 | 20,033,898 |
| 价格/销量 (P/S) | 5.77 |
| 股市价格/股市净资产 (P/B) | 9.31 |
| 52周波幅 | |
| 利润日期 | 12 Dec 2024 - 16 Dec 2024 |
| 营业利益率 (TTM) | -338.34% |
| 稀释每股收益 (EPS TTM) | -0.480 |
| 季度收入增长率 (YOY) | 31.10% |
| 总债务/股东权益 (D/E MRQ) | 9.63% |
| 流动比率 (MRQ) | 2.42 |
| 营业现金流 (OCF TTM) | -11.25 M |
| 杠杆自由现金流 (LFCF TTM) | -6.99 M |
| 资产报酬率 (ROA TTM) | -143.33% |
| 股东权益报酬率 (ROE TTM) | -349.13% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | NeuroOne Medical Technologies C | 混合的 | 混合的 |
AIStockmoo 评分
-0.3
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -2.5 |
| 平均 | -0.33 |
|
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Core |
| 内部持股比例 | 10.19% |
| 机构持股比例 | 19.59% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Nantahala Capital Management, Llc | 30 Sep 2024 | 798,762 |
| Perkins Capital Management Inc | 30 Sep 2024 | 150,000 |
| Blair William & Co/Il | 30 Sep 2024 | 55,556 |
| Mai Capital Management | 30 Sep 2024 | 50,000 |
| Princeton Global Asset Management Llc | 30 Sep 2024 | 16,833 |
| Marcum Wealth, Llc | 30 Sep 2024 | 12,000 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合